Tomonori Terada

Hyogo Medical University

Papers

1

Total Citations

28

H-Index

1

About

Tomonori Terada is a leading figure in head and neck surgical oncology, with a primary focus on minimally invasive treatments for oropharyngeal, hypopharyngeal, and supraglottic squamous cell carcinoma. His most impactful work, a multi-center retrospective observational study published in 2021, systematically compared treatment outcomes between transoral robotic surgery (TORS) and non-robotic surgical approaches across Japan. This landmark study, cited 28 times, provided crucial evidence on the efficacy and safety of robotic-assisted techniques, helping to establish TORS as a viable alternative to traditional open surgeries in select patient populations. Terada’s contributions have advanced the understanding of how surgical innovation can reduce morbidity while maintaining oncologic control, directly influencing clinical guidelines and surgical decision-making in Japan and beyond. His research bridges the gap between emerging technology and practical patient care, offering valuable insights for surgeons and trainees navigating the evolving landscape of head and neck cancer treatment.

Research Focus

Key Achievements

1
H-Index
1
Papers
28
Total Citations
28
Avg Citations/Paper
🏆 Most Cited Paper
Treatment outcomes of transoral robotic and non-robotic surgeries to treat oropharyngeal, hypopharyngeal, and supraglottic squamous cell carcinoma: A multi-center retrospective observational study in Japan
28 citations · 2021
📈 Most Prolific Year: 2021 (1 Papers)
🤝 Key Collaborators: 17
🏛 Institutions: Hyogo Medical University

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago